Valeritas

Valeritas is a medical technology company based in Bridgewater, New Jersey, founded in 2006. It specializes in developing innovative technologies for managing Type 2 diabetes. The company focuses on medical devices that enhance insulin delivery, with its flagship product being the V-Go, a wearable insulin delivery device designed for basal-bolus therapy. This device simplifies insulin administration, providing continuous basal insulin delivery along with on-demand bolus dosing to improve patient adherence and glycemic control. In addition to the V-Go, Valeritas is working on the V-Go Prefill, which aims to streamline the device-filling process and eliminate refrigeration needs, and the V-Go SIM, a digital solution for real-time tracking of insulin dosing. Valeritas markets its products through third-party wholesalers and medical supply distributors, targeting healthcare providers and patients in the U.S. The company is positioned for growth, with plans for a public listing to support its expansion in the medical device sector.

• Employees 35
• Founded 2006
• Annual Revenue $29274000
• Total Funding $333855420